Skip to main content
Premium Trial:

Request an Annual Quote

DxS, ParAllele BioScience, Translational Genomics Research Institute


DxS has launched a single-tube genotyping assay in its Scorpions fluorescent-detection technology line for the drug-metabolism gene UGT 1A1*28, the company said last week. The test can deliver results "within 30 minutes" and can be used with both real-time or end-point analysis, the company said.

ParAllele BioScience now offers 20,000 non-synonymous SNPs — up from 10,000 — as part of its human genotyping service, the company said last week. The latest SNP selection was obtained by genotyping "approximately 300" individuals from three ethnic populations, resulting in "more than 8 million" genotypes, the company said.

The Translational Genomics Research Institute has launched its MammaPrint gene-expression profile microarray diagnostic for breast cancer in the United States, the company said in a statement this week. The test "distinguishes between lymph node-negative breast cancer patients who would benefit from additional therapy from those who would not," the company said.

Filed under

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.